ctrl K

Advertisement

Compass Therapeutics Inc. (CMPX)

NASDAQ: CMPX · Real-Time Price · USD

1.90

0.00 (0.00%)

Apr 29, 2025, 11:00 AM - Market open

Compass Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Mar 31, 2020	Mar 31, 2019
Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	1.89M	1.9M	1.62M	2.4M	2.12M	1.92M
Gross Profit	-1.89M	-1.9M	-1.62M	-2.4M	-2.12M	-1.92M
Operating Income	-50.36M	-41.66M	-81.88M	-27.81M	-34.05M	-38.31M
Interest Income	n/a	2.36M	29K	88K	743K	663K
Pretax Income	-42.49M	-39.23M	-82.18M	-29.47M	-34.65M	-38.18M
Net Income	-42.49M	-36.8M	-82.55M	-29.5M	-34.74M	-38.29M
Selling & General & Admin	11.05M	11.66M	10.93M	12.91M	11.6M	11.22M
Research & Development	37.42M	30M	20.34M	14.9M	22.45M	27.09M
Other Expenses	n/a	n/a	50.62M	n/a	n/a	n/a
Operating Expenses	48.47M	41.66M	31.26M	27.81M	34.05M	38.31M
Interest Expense	n/a	2.36M	370K	908K	1.23M	767K
Selling & Marketing Expenses	11.04M	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	50.36M	41.66M	31.26M	27.81M	34.05M	38.31M
Income Tax Expense	n/a	-2.43M	370K	32K	91K	103K
Shares Outstanding (Basic)	127.03M	105.19M	62.87M	30.78M	52.11M	52.11M
Shares Outstanding (Diluted)	127.03M	105.19M	62.87M	30.78M	52.11M	52.11M
EPS (Basic)	-0.33	-0.35	-1.31	-0.96	-0.67	-0.73
EPS (Diluted)	-0.33	-0.35	-1.31	-0.96	-0.67	-0.73
EBITDA	-48.47M	-37.39M	-29.61M	-25.32M	-31.19M	-35.73M
EBIT	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	1.89M	1.9M	1.62M	2.4M	2.12M	1.92M